prednisolone has been researched along with Congenital Erythropoietic Porphyria in 2 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CHATTERJEA, JB | 1 |
| Venkatesh, P | 1 |
| Garg, SP | 1 |
| Kumaran, E | 1 |
| Tewari, HK | 1 |
1 review available for prednisolone and Congenital Erythropoietic Porphyria
| Article | Year |
|---|---|
Congenital porphyria with necrotizing scleritis in a 9-year-old child.
Topics: Atropine; Child; Eye Protective Devices; Humans; Male; Necrosis; Ophthalmic Solutions; Porphyria, Er | 2000 |
1 other study available for prednisolone and Congenital Erythropoietic Porphyria
| Article | Year |
|---|---|
ERYTHROPOIETIC PORPHYRIA.
Topics: Autoimmune Diseases; Cell Death; Child; Erythropoiesis; Hemolysis; Humans; Porphyria, Erythropoietic | 1964 |